SCHEMBL2396267

SCHEMBL2396267

CC12CCCc3cc(C(=O)Nc4ccc(C(=O)O)s4)cc(c31)CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEH1 O60930 1/20 0.38
AR P10275 5/20 0.37
NR3C1 P04150 5/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TP53 P04637 2/20 0.36
MAPT P10636 2/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
DAO P14920 1/20 0.36
ALDH1A1 P00352 1/20 0.36
P2RY14 Q15391 3/20 0.34
RXRA P19793 3/20 0.34
RXRB P28702 3/20 0.34
RXRG P48443 3/20 0.34
PTGER3 P43115 1/20 0.34
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2395484 0.91 AR (0.41) RNASEH1ARNR3C1NPC1RAB9A
SCHEMBL2397421 0.81 NPC1 (0.45) NPC1RAB9ATP53MAPTNFKB1
SCHEMBL2398284 0.79 RNASEH1 (0.41) RNASEH1ARNR3C1NPC1RAB9A
SCHEMBL2394957 0.78 MEN1 (0.54) NPC1RAB9ATP53MAPTNFKB1
SCHEMBL829839 0.75 ALDH1A1 (0.46) MAPTALDH1A1RXRARXRBRXRG
SCHEMBL2395760 0.74 HCAR3 (0.53) RARARARBRARG
SCHEMBL11955422 0.74 MEN1 (0.55) NPC1RAB9ATP53MAPTNFKB1
SCHEMBL2394353 0.74 NPC1 (0.50) NPC1RAB9ATP53MAPTSMN1; SMN2
SCHEMBL2392941 0.74 KMT2A (0.54) NPC1RAB9ATP53MAPTNFKB1
SCHEMBL2394385 0.73 CPT2 (0.44) NPC1RAB9ATP53MAPTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2189443-B1 TRICYCLIC AMIDE COMPOUND RES FOUND ITSUU LAB (JP) 2013-10-23 EP disclosed
US-8232300-B2 Tricyclic amide compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-07-31 US disclosed
US-8232300-B2 Tricyclic amide compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-07-31 US disclosed
US-8232300-B2 Tricyclic amide compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-07-31 US disclosed
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RXRA, RXRB, RXRG RNASEH1 938/4885AR 74/4885NR3C1 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.